SC0T:XETRA:XETRA-Invesco Markets plc - Invesco STOXX Europe 600 Optimised Health Care UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 385.4

Change

0.00 (0.00)%

Market Cap

USD 0.01B

Volume

53.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.11 (-0.21%)

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.03 (-0.18%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.12 (-0.44%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.14 (-0.49%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.09 (+0.36%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-0.10 (-0.07%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

+0.04 (+0.08%)

USD 102.57B
8R80:XETRA Amundi Index Solutions - Amund..

+0.40 (+0.28%)

USD 102.14B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.09 (-0.17%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+2.84 (+0.55%)

USD 80.38B

ETFs Containing SC0T:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.71% 66% D+ 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.71% 65% D 65% D
Trailing 12 Months  
Capital Gain 2.49% 30% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.49% 29% F 35% F
Trailing 5 Years  
Capital Gain 51.67% 73% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 51.67% 72% C 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 7.61% 68% D+ 66% D+
Dividend Return 7.61% 67% D+ 63% D
Total Return N/A 71% C- 67% D+
Risk Return Profile  
Volatility (Standard Deviation) 8.68% 66% D+ 74% C
Risk Adjusted Return 87.68% 96% N/A 95% A
Market Capitalization 0.01B 10% F 9% A-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.